Should doctors prescribe Leqembi (lecanemab) to women with early Alzheimer’s Disease? The evidence-based answer is probably No

By SharpBrains | June 28, 2023

Wel­come to a new edi­tion of Sharp­Brains e‑newsletter, fea­tur­ing this time a range of inter­ven­tions for brain/ cognitive/ men­tal health plus a few brain teasers to test our per­cep­tion and cog­ni­tive skills. #1. Should doc­tors pre­scribe lecanemab (Leqem­bi) to women? The answer, giv­en avail­able evi­dence, is prob­a­bly No Huge (and most­ly over­looked) red flag regard­ing newly…

Read More

On the 7 Habits of Highly Stress-Resilient Minds, cognitive screenings, anti-amyloid drugs, and more

By SharpBrains | April 27, 2023

Wel­come to a new edi­tion of Sharp­Brains e‑newsletter, this time cov­er­ing the lat­est devel­op­ments in stress research, med­i­ta­tion, vir­tu­al real­i­ty, anti-amy­loid drugs, cog­ni­tive screen­ings, and more. #1. The 7 Habits of High­ly Stress-Resilient Minds “Any­thing worth doing will have aspects of stress woven through: chal­lenge, dis­com­fort, risk. We can’t change that. But what we can change is…

Read More